Clinical Trial Update: TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

TAK-648 was evaluated in a Phase 1 multiple-rising-dose study in healthy Japanese and non-Japanese participants with Type 2 Diabetes Mellitus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• TAK-648

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Phase 1 | Status: COMPLETED | Results posted: 2016-08-31